Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Enzomenib is an investigational new drug that is being evaluated for the treatment of acute leukemia. It is a small molecule inhibitor that targets the interaction between menin and mixed-lineage leukemia (MLL) proteins. Enzomenib targets tumors with KMT2A (MLL) rearrangements or NPM1 mutations.
Overview, Related Topics & Entities
Explore the main themes, entities and connections around Enzomenib. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
drug leukemia targets mll menin investigational new evaluated treatment acute small molecule inhibitor interaction mixed-lineage proteins tumors kmt2a rearrangements npm1
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Enzomenib | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Enzomenib | CAS Number | 2412555-70-3 | 1.00 | infobox |
| Enzomenib | ChEMBL | ChEMBL5314915 | 1.00 | infobox |
| Enzomenib | ChemSpider | 129534736 | 1.00 | infobox |
| Enzomenib | DrugBank | DB18514 | 1.00 | infobox |
| Enzomenib | Formula | C33H43FN6O3 | 1.00 | infobox |
| Enzomenib | KEGG | D13193 | 1.00 | infobox |
| Enzomenib | Molar mass | 590.744 g·mol−1 | 1.00 | infobox |
| Enzomenib | Other names | DSP-5336 | 1.00 | infobox |
| Enzomenib | PubChem CID | 146430058 | 1.00 | infobox |
| Enzomenib | UNII | VW83Y2JLZ5 | 1.00 | infobox |
| Enzomenib | is a | investigational new drug that is being evaluated for the treatment of acute leukemia | 0.90 | text |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.